{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:30:21Z","timestamp":1793305821804,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Emerging evidence implies a link between high pediatric body mass index (BMI) and an increased risk of multiple sclerosis (MS). However, previous research suggests this association is only present for adolescent obesity and not childhood obesity. The present study aimed to assess the association between pediatric obesity and risk of developing MS, and to investigate if degree of obesity and age at obesity treatment initiation affects the risk. In a subgroup, response to obesity treatment on MS risk was assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this cohort study, patients aged 2\u201319 years from the Swedish Childhood Obesity Treatment Register (BORIS), and matched individuals from the general population were followed prospectively. MS was identified through the National Patient Register. Hazard ratios (HR) adjusted for parental MS were calculated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The study included 21,652 individuals with pediatric obesity and 102,187 general population comparators. The median age at follow-up was 21 (Q1, Q3 18, 25) years. The adjusted HR (95% CI) for developing MS in the pediatric obesity cohort was 2.28 (1.45\u20133.58). In stratified analyses, obesity class I was not associated with MS, HR\u2009=\u20091.34 (0.64\u20132.81), while the association between obesity class II and MS was strengthened, HR\u2009=\u20093.42 (1.89\u20136.19). MS was associated with both childhood obesity, HR\u2009=\u20093.16 (1.12\u20138.87), and adolescent obesity, HR\u2009=\u20092.12 (1.28\u20133.51). A decrease in BMI SDS was not associated with lower likelihood of MS, HR\u2009=\u20091.09 (0.92\u20131.29) per 0.25 BMI SDS unit decrease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Both childhood and adolescent obesity are associated with an increased risk of MS. Moreover, a dose-response relationship between the degree of obesity and the risk of future MS was indicated, while response to pediatric obesity treatment did not affect the association, highlighting the importance of preventing high degree of obesity early in life.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s41366-025-01727-3","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T06:30:58Z","timestamp":1738218658000},"page":"1031-1036","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pediatric obesity and the risk of multiple sclerosis: a nationwide prospective cohort study"],"prefix":"10.1038","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1433-2295","authenticated-orcid":false,"given":"Emilia","family":"Hagman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Resthie R.","family":"Putri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4674-2638","authenticated-orcid":false,"given":"Pernilla","family":"Danielsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0890-2650","authenticated-orcid":false,"given":"Claude","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"1727_CR1","doi-asserted-by":"publisher","first-page":"e1003078","DOI":"10.1371\/journal.pmed.1003078","volume":"17","author":"L Lindberg","year":"2020","unstructured":"Lindberg L, Danielsson P, Persson M, Marcus C, Hagman E. Association of childhood obesity with risk of early all-cause and cause-specific mortality: A Swedish prospective cohort study. PLoS Med. 2020;17:e1003078.","journal-title":"PLoS Med"},{"key":"1727_CR2","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/joim.13547","volume":"292","author":"C Marcus","year":"2022","unstructured":"Marcus C, Danielsson P, Hagman E. Pediatric obesity-Long-term consequences and effect of weight loss. J Intern Med. 2022;292:870\u201391.","journal-title":"J Intern Med"},{"key":"1727_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-1498-z","volume":"18","author":"L Lindberg","year":"2020","unstructured":"Lindberg L, Hagman E, Danielsson P, Marcus C, Persson M. Anxiety and depression in children and adolescents with obesity: a nationwide study in Sweden. BMC Med. 2020;18:30.","journal-title":"BMC Med"},{"key":"1727_CR4","doi-asserted-by":"publisher","first-page":"e040432","DOI":"10.1136\/bmjopen-2020-040432","volume":"11","author":"L Lindberg","year":"2021","unstructured":"Lindberg L, Persson M, Danielsson P, Hagman E, Marcus C. Obesity in childhood, socioeconomic status, and completion of 12 or more school years: a prospective cohort study. BMJ Open. 2021;11:e040432.","journal-title":"BMJ Open"},{"key":"1727_CR5","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1177\/1352458513483889","volume":"19","author":"KL Munger","year":"2013","unstructured":"Munger KL, Bentzen J, Laursen B, Stenager E, Koch-Henriksen N, Sorensen TI, et al. Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler. 2013;19:1323\u20139.","journal-title":"Mult Scler"},{"key":"1727_CR6","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1177\/1352458512436596","volume":"18","author":"AK Hedstrom","year":"2012","unstructured":"Hedstrom AK, Olsson T, Alfredsson L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler. 2012;18:1334\u20136.","journal-title":"Mult Scler"},{"key":"1727_CR7","doi-asserted-by":"crossref","unstructured":"Mandato C, Colucci A, Lanzillo R, Staiano A, Scarpato E, Schiavo L et al. Multiple Sclerosis-Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics. Children. 2023;10:1022.","DOI":"10.3390\/children10061022"},{"key":"1727_CR8","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1093\/ije\/dyaa151","volume":"49","author":"J Pakpoor","year":"2021","unstructured":"Pakpoor J, Schmierer K, Cuzick J, Giovannoni G, Dobson R. Estimated and projected burden of multiple sclerosis attributable to smoking and childhood and adolescent high body-mass index: a comparative risk assessment. Int J Epidemiol. 2021;49:2051\u20137.","journal-title":"Int J Epidemiol"},{"key":"1727_CR9","doi-asserted-by":"crossref","unstructured":"Milles P, De Filippo G, Maurey H, Tully T, Deiva K, KidBiosep. Obesity in Pediatric-Onset Multiple Sclerosis: A French Cohort Study. Neurol Neuroimmunol Neuroinflamm. 2021;8:e1044.","DOI":"10.1212\/NXI.0000000000001044"},{"key":"1727_CR10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/acn3.51291","volume":"8","author":"M Marrodan","year":"2021","unstructured":"Marrodan M, Farez MF, Balbuena Aguirre ME, Correale J. Obesity and the risk of Multiple Sclerosis. The role of Leptin. Ann Clin Transl Neurol. 2021;8:406\u201324.","journal-title":"Ann Clin Transl Neurol"},{"key":"1727_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1212\/WNL.0000000000000203","volume":"82","author":"AK Hedstrom","year":"2014","unstructured":"Hedstrom AK, Lima Bomfim I, Barcellos L, Gianfrancesco M, Schaefer C, Kockum I, et al. Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology. 2014;82:865\u201372.","journal-title":"Neurology"},{"key":"1727_CR12","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1016\/j.orcp.2014.01.002","volume":"8","author":"MA Gianfrancesco","year":"2014","unstructured":"Gianfrancesco MA, Acuna B, Shen L, Briggs FB, Quach H, Bellesis KH, et al. Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors. Obes Res Clin Pr. 2014;8:e435\u201347.","journal-title":"Obes Res Clin Pr"},{"key":"1727_CR13","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1177\/13524585211001781","volume":"27","author":"A Harroud","year":"2021","unstructured":"Harroud A, Mitchell RE, Richardson TG, Morris JA, Forgetta V, Davey Smith G, et al. Childhood obesity and multiple sclerosis: A Mendelian randomization study. Mult Scler. 2021;27:2150\u20138.","journal-title":"Mult Scler"},{"key":"1727_CR14","doi-asserted-by":"crossref","unstructured":"Jacobs BM, Noyce AJ, Giovannoni G, Dobson R. BMI and low vitamin D are causal factors for multiple sclerosis: A Mendelian Randomization study. Neurol Neuroimmunol Neuroinflamm. 2020;7:e662.","DOI":"10.1212\/NXI.0000000000000662"},{"key":"1727_CR15","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1177\/1352458515603798","volume":"22","author":"AK Hedstrom","year":"2016","unstructured":"Hedstrom AK, Olsson T, Alfredsson L. Body mass index during adolescence, rather than childhood, is critical in determining MS risk. Mult Scler. 2016;22:878\u201383.","journal-title":"Mult Scler"},{"key":"1727_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","volume":"13","author":"T Olsson","year":"2017","unstructured":"Olsson T, Barcellos LF, Alfredsson L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol. 2017;13:25\u201336.","journal-title":"Nat Rev Neurol"},{"key":"1727_CR17","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1212\/WNL.0b013e3181c0d6e0","volume":"73","author":"KL Munger","year":"2009","unstructured":"Munger KL, Chitnis T, Ascherio A. Body size and risk of MS in two cohorts of US women. Neurology. 2009;73:1543\u201350.","journal-title":"Neurology"},{"key":"1727_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.2047-6310.2012.00064.x","volume":"7","author":"TJ Cole","year":"2012","unstructured":"Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes. 2012;7:284\u201394.","journal-title":"Pediatr Obes"},{"key":"1727_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12626","volume":"15","author":"E Hagman","year":"2020","unstructured":"Hagman E, Danielsson P, Lindberg L, Marcus C, Committee BS. Paediatric obesity treatment during 14 years in Sweden: Lessons from the Swedish Childhood Obesity Treatment Register-BORIS. Pediatr Obes. 2020;15:e12626.","journal-title":"Pediatr Obes"},{"key":"1727_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","volume":"31","author":"JF Ludvigsson","year":"2016","unstructured":"Ludvigsson JF, Almqvist C, Bonamy AK, Ljung R, Michaelsson K, Neovius M, et al. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016;31:125\u201336.","journal-title":"Eur J Epidemiol"},{"key":"1727_CR21","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s10654-019-00558-7","volume":"34","author":"C Murley","year":"2019","unstructured":"Murley C, Friberg E, Hillert J, Alexanderson K, Yang F. Validation of multiple sclerosis diagnoses in the Swedish National Patient Register. Eur J Epidemiol. 2019;34:1161\u20139.","journal-title":"Eur J Epidemiol"},{"key":"1727_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/imr.13343","volume":"325","author":"TL Montgomery","year":"2024","unstructured":"Montgomery TL, Peipert D, Krementsov DN. Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: Complex interactions between host genetics, bacterial metabolism, and diet. Immunol Rev. 2024;325:131\u201351.","journal-title":"Immunol Rev"},{"key":"1727_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S2352-4642(18)30022-1","volume":"2","author":"SM Sawyer","year":"2018","unstructured":"Sawyer SM, Azzopardi PS, Wickremarathne D, Patton GC. The age of adolescence. Lancet Child Adolesc Health. 2018;2:223\u20138.","journal-title":"Lancet Child Adolesc Health"},{"key":"1727_CR24","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.3389\/fimmu.2019.01881","volume":"10","author":"Z Ji","year":"2019","unstructured":"Ji Z, Wu S, Xu Y, Qi J, Su X, Shen L. Obesity Promotes EAE Through IL-6 and CCL-2-Mediated T Cells Infiltration. Front Immunol. 2019;10:1881.","journal-title":"Front Immunol"},{"key":"1727_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104768","volume":"76","author":"A Samara","year":"2023","unstructured":"Samara A, Cantoni C, Piccio L, Cross AH, Chahin S. Obesity, gut microbiota, and multiple sclerosis: Unraveling the connection. Mult Scler Relat Disord. 2023;76:104768.","journal-title":"Mult Scler Relat Disord"},{"key":"1727_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.17712\/nsj.2018.2.20170343","volume":"23","author":"MH Alanazy","year":"2018","unstructured":"Alanazy MH, Alomar MA, Aljafen BN, Muayqil TA. Multiple sclerosis and myasthenia gravis following severe weight loss. Neuroscience. 2018;23:158\u201361.","journal-title":"Neuroscience"},{"key":"1727_CR27","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1159\/000515374","volume":"14","author":"S Asakly","year":"2021","unstructured":"Asakly S, Magen-Rimon R, Ighbariya A, Marjih-Shallufi M, Ben-Porat T, Ravid S, et al. Bariatric Surgery-Associated Myelopathy. Obes Facts. 2021;14:431\u20139.","journal-title":"Obes Facts"},{"key":"1727_CR28","first-page":"41","volume":"16","author":"S Bitarafan","year":"2017","unstructured":"Bitarafan S, Amani K, Sahraian MA, Sarraf P, Soltani D, Moghadasi AN, et al. The first attack of multiple sclerosis presented immediately after voluntary and intensive weight loss: A case series. Iran J Neurol. 2017;16:41\u201342.","journal-title":"Iran J Neurol"},{"key":"1727_CR29","doi-asserted-by":"publisher","DOI":"10.1177\/17562864241241383","volume":"17","author":"A Shirani","year":"2024","unstructured":"Shirani A, Cross AH, Stuve O. Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database. Ther Adv Neurol Disord. 2024;17:17562864241241383.","journal-title":"Ther Adv Neurol Disord"},{"key":"1727_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrneurol.2017.33","volume":"13","author":"RA Marrie","year":"2017","unstructured":"Marrie RA. Comorbidity in multiple sclerosis: implications for patient care. Nat Rev Neurol. 2017;13:375\u201382.","journal-title":"Nat Rev Neurol"},{"key":"1727_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/jnnp-2016-315037","volume":"88","author":"P Tettey","year":"2017","unstructured":"Tettey P, Simpson S, Taylor B, Ponsonby AL, Lucas RM, Dwyer T, et al. An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event. J Neurol Neurosurg Psychiatry. 2017;88:395\u2013401.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-025-01727-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-025-01727-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-025-01727-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T13:52:00Z","timestamp":1749649920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-025-01727-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1727"],"URL":"https:\/\/doi.org\/10.1038\/s41366-025-01727-3","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and approved by the regional ethical committee in Stockholm, Sweden (reference numbers 2016\/922-31\/1 and 2020-02707). The need for patient consent was waived due to anonymized register data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}